








Prenatal alcohol exposure and childhood atopic disease: a Mendelian randomization approach
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Background:  Alcohol consumption in western pregnant women is not uncommon and could be a risk factor for childhood atopic disease. However, reported alcohol intake may be unreliable and associations are likely to be confounded.
Objective: To study the relation between prenatal alcohol exposure and atopic phenotypes in a large population-based birth cohort using a Mendelian randomization approach in order to minimise bias and confounding. 
Methods: In white mothers and children in the Avon Longitudinal Study of Parents and Children (ALSPAC) we first analysed associations between reported maternal alcohol consumption during pregnancy and atopic outcomes in the offspring measured at 7 years of age (asthma, wheezing, hayfever, eczema, atopy and total IgE). We then analysed the relation of maternal alcohol dehydrogenase (ADH)1B genotype (rs1229984) with these outcomes (the A allele is associated with faster metabolism and reduced alcohol consumption and, amongst drinkers, would be expected to reduce fetal exposure to ethanol).
Results: After controlling for confounders, reported maternal drinking in late pregnancy was negatively associated with childhood asthma and hayfever (adjusted odds ratio (95% CI) per category increase in intake: 0.91 (0.82 to 1.01) and 0.87 (0.78 to 0.98), respectively).  However, maternal ADH1B genotype was not associated with asthma (OR (95% CI) comparing carriers of A allele with individuals homozygous for G allele: 0.98 (0.66 to 1.47)) or hayfever (OR 1.11 (0.71 to 1.72)), nor with any other atopic outcome.  




Whilst pregnant women should be advised to abstain from alcohol, this study has reassuringly found no evidence that alcohol exposure in utero increases the risk of atopic disease in the offspring. 

Capsule summary
This study, using a Mendelian randomization approach to minimise bias and confounding (which may occur when using reported alcohol consumption), has reassuringly found no evidence to suggest that prenatal alcohol exposure increases the risk of childhood atopic disease. 
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Introduction
Experiments in animals have shown that short-term alcohol exposure inhibits Th1 responses and increases Th2 cytokine responses and IgE1;2, although longer-term consumption has been shown to reduce airway hyper-responsiveness and allergic inflammation in an adult mouse model3.  Also, prenatal exposure can impair fetal lung growth and development4-6, through increased oxidative stress7.  In humans, reported alcohol intake is positively associated with total IgE cross-sectionally, although associations with allergen-specific sensitisation have been inconsistent8-10.  Studies from Denmark have found that reported alcohol consumption in pregnancy was positively associated with total IgE in cord blood11 and postnatal atopic dermatitis12;13, but not with hospitalisation for asthma in childhood14.  Given these data, and that the prevalence of low to moderate alcohol consumption during pregnancy is high (30-59%) in the UK, Denmark, Sweden, Australia and the USA15-20, it would seem important to establish whether prenatal alcohol exposure might be contributing to the high prevalence of childhood atopic disease in the west21.  
One difficulty with using reported alcohol intake in pregnancy to measure exposure is that under-reporting of consumption is common22 and, as with all observational studies, associations may arise spuriously through bias, or because of unmeasured or residual confounding, a particular problem in nutritional epidemiology23.  Randomised trials of alcohol exposure in pregnancy would be unethical and we are not aware of any trials of alcohol avoidance in pregnancy which have evaluated childhood atopic outcomes. However, causal inference can be strengthened in observational studies by using Mendelian randomization to reduce measurement error and minimise bias and confounding24;25.  This approach hinges on the principle that genotype is randomly allocated during meiosis, and consequently associations between genetic variants and disease are not generally susceptible to confounding by lifestyle factors. Also, variants should not be associated with the disease outcome of interest except through their link to the modifiable risk process of interest. In the case of alcohol, a non-synonymous variant in the alcohol metabolising gene, alcohol dehydrogenase (ADH)1B, is thought to accelerate ethanol clearance and inhibit heavy drinking26, and can be used as a proxy for alcohol consumption. The A allele is associated with faster conversion of alcohol to acetaldehyde and this leads to reduced alcohol consumption. In European populations, this ADH1B variant is associated with aerodigestive cancers27, thus providing convincing evidence that alcohol causes these conditions.  Furthermore, in the Avon Longitudinal Study of Parents and Children (ALSPAC), a UK population based birth cohort, the maternal ADH1B gene variant was strongly associated with alcohol use before and during pregnancy, suggesting that it could be used as a reliable instrument to study the consequences of prenatal (and peri-conceptional) alcohol exposure28.  Indeed, in order to study the relation between fetal alcohol exposure and cognitive development, we recently used a Mendelian randomisation approach in ALSPAC to determine whether genetic variants in alcohol metabolising genes were associated with childhood IQ29.  





The Avon Longitudinal Study of Parents and Children (ALSPAC) is a population-based birth cohort that recruited 14,541 predominantly white pregnant women resident in the Bristol area of the UK during 1990-92. There were 14,062 live born children and 13,988 of these children were alive at age one year and subsequently followed up. The cohort has been followed since birth with annual questionnaires and, since age 7 years, with objective measures in annual research clinics. The study protocol has been described previously30;31  and further information can be found at: http://www.alspac.bris.ac.uk.  Ethics approval for all aspects of data collection was obtained from the ALSPAC Ethics and Law Committee (IRB 00003312) and the Local Research Ethics Committees.

Exposures
Mothers were asked 8 weeks into their pregnancy to report their current alcohol consumption (how many measures of beer, wine, spirit or other alcoholic drinks per day on weekdays and weekends), from which the total units/week were derived and then grouped to avoid categories with small numbers (Never, 1-2 units/week, 3-4 units/week, 5+ units/week).  At 18 weeks gestation mothers were asked to recall their alcohol consumption just before the current pregnancy (derived categories: Never, <1 units/week, 1-6 units/week, 7+ units/week) and in the first three months of pregnancy (Never, <1 unit/week, >1 unit/week).  (Asking about drinking habits just before pregnancy is likely to capture intake in very early gestation, before mothers have realised that they have conceived and had a chance to alter their drinking behaviour).  At 8 weeks after delivery mothers were asked to report their consumption in the last two months of pregnancy (Never, <1 unit/week, >1 unit/week).  We also defined mothers as ‘binge’ drinkers if they reported drinking at least 4 units on one or more days (never, 1-2days, 3+ days) in the previous month when asked at 18 weeks gestation28.  

Outcomes
When the children were 7.5 years old, mothers were asked: ‘Has your child had any of the following in the past 12 months: wheezing; asthma; eczema; hayfever?’.  Children were defined as having current doctor-diagnosed asthma at 7.5 years (primary outcome of interest) if mothers responded positively to the question ‘Has a doctor ever actually said that your study child has asthma?’ and positively to one or both of the questions on wheezing and asthma in the past 12 months. 
Atopy at 7 years was defined as a positive reaction (any detectable weal) to D. pteronyssinus, cat or grass (after subtracting positive saline reactions from histamine and allergen weals, and excluding children unreactive to 1% histamine).  (Atopy defined in this way identified 96% of children sensitised to 26 other allergens in this cohort32). Serum total IgE (kU/l) was measured by fluoroimmunoassay using the Pharmacia UNICAP system (Pharmacia & Upjohn Diagnostics AB, Uppsala, Sweden). 

Confounders 
In multivariate analyses we controlled for the following potential confounders: maternal factors during pregnancy (smoking, infections, anxiety score, antibiotic use and paracetamol use); other maternal factors (educational level, housing tenure, financial difficulties, body mass index, age, parity, history of asthma, eczema, rhinoconjunctivitis, migraine); sex of child, season of birth, multiple pregnancy, gestational age, birthweight, head circumference, birth length; postnatal factors (breast feeding, day care, pets, damp/mould, environmental tobacco smoke exposure, antibiotic and paracetamol use in infancy, number of younger siblings, BMI at age 7).  

Genotyping
The majority of maternal DNA samples were extracted from whole blood and white cells taken during pregnancy and a minority were buccal DNA extracted from mouthwash samples. A single nucleotide polymorphism (SNP) (rs1229984 in ADH1B) was typed by KBiosciences Ltd (Hoddesdon, Herts, UK; www.kbioscience.co.uk) using a competitive allele specific PCR system (KASPar).  The genotype distribution was compatible with no departure from Hardy-Weinberg equilibrium and the genotyping success rate was above 93.3% and error rate below 0.25%28. 

Statistical analyses
Although the ALSPAC population is largely white, we adopted two strategies to reduce the possibility of confounding by population substructure, since the rs1229984 variant is highly ethnically stratified.  First, mother-child pairs were excluded from all analyses if the mother’s reported ethnicity was non-white or unknown.  Second, in order to address possible residual confounding by population substructure, we  controlled for ten variables derived by principal components analysis (PCA) from ALSPAC genome-wide association study (GWAS) data. 





Table 1 shows the association between reported alcohol intake in the last two months of pregnancy and other maternal characteristics, amongst mothers for whom data were complete for at least one childhood atopic outcome.  Mothers who reported drinking alcohol were more likely than those who reported never drinking to be older, better educated, financially better off, to have taken paracetamol in pregnancy. In contrast, Table 2 shows that the distribution of maternal ADH1B genotype broadly does not vary according to maternal or offspring characteristics.  

Table E1 shows the association between maternal ADH1B genotype and reported maternal alcohol intake before and during pregnancy.  As expected, carriers of the A allele reported a lower intake than those homozygous for the G allele both before and during pregnancy, they were less likely to report binge drinking, and they were more likely to report abstaining from alcohol during pregnancy.  

Table 3 shows the association between self-reported alcohol consumption before and during pregnancy and childhood asthma in individuals with complete outcome data.  Univariately, there was weak evidence for a lower prevalence of asthma in children of mothers who reported consuming alcohol in the last two months of pregnancy.  After controlling for confounders, there was still weak evidence for a lower prevalence of asthma in mothers who reported consuming alcohol in the first three months (P trend 0.047) and last two months of pregnancy (P trend 0.074). Table 4 shows that, after controlling for confounders, reported maternal alcohol intake in late pregnancy was negatively associated with hayfever in the offspring (P trend 0.024).  Tables E2-E5 show the associations between reported alcohol consumption before and during pregnancy and childhood wheezing, eczema, atopy and IgE.  After controlling for confounders, maternal intake was not associated with any outcome.  
Table 5 shows the associations between maternal ADH1B genotype and childhood atopic outcomes.  Univariately there was no association with any outcome.  Similarly, amongst individuals with available PCA variables derived from GWAS data, maternal genotype was not associated with any outcome, either univariately, or after controlling for all potential confounders, including the ten PCA variables. 




In this population based birth cohort we have shown, using a Mendelian randomization approach, that a maternal ADH1B gene variant (rs1229984), as a proxy for prenatal alcohol exposure, was unrelated to childhood atopic outcomes, suggesting that alcohol consumption during pregnancy is unlikely to be an important cause of these disorders.  This conclusion is further reinforced by the lack of evidence for an interaction between maternal ADH1B and reported intake of alcohol in pregnancy; such an interaction, with a weaker or absent effect of the gene in mothers reporting no alcohol intake, would have been expected if there was a causal effect of prenatal alcohol exposure33.  The lack of evidence of association between maternal ADH1B genotype and atopic outcomes in the offspring also suggests that maternal consumption of alcohol before, or peri-conception, is unlikely to influence childhood asthma and allergies; in ALSPAC the same non-synonymous variant of ADH1B is strongly associated with alcohol use just before, as well as during, pregnancy28. 
Given the principles underpinning Mendelian randomization34;35, our genetic findings are much less likely to be confounded by lifestyle or environmental factors than the weak negative associations we observed between reported maternal alcohol intake in late pregnancy and risk of asthma and hayfever in the offspring.  Mothers who drank alcohol in pregnancy tended to be older, better educated and financially better off than mothers who abstained.  Although we controlled for a large number of socio-economic and other background characteristics in the analyses of reported maternal drinking, the possibility of residual or uncontrolled confounding remains.  Furthermore, the negative associations between reported maternal intake and childhood asthma and hayfever conflict with the few previous epidemiological studies which have suggested a positive relation between prenatal alcohol exposure and atopic outcomes11-13. Whilst there is some evidence for a protective effect of alcohol on allergic airway inflammation and airway hyper-responsiveness in an adult mouse model of allergic asthma3, the mechanisms underlying such an effect, and the relevance of these observations to the inception of asthma following prenatal exposure in humans are unclear. Also, other animal data indicate detrimental effects of prenatal exposure on fetal lung growth and development4-6.  The findings for hayfever, if real, would be expected to be mediated through an effect on atopy, yet we did not find similar negative associations between reported intake and atopy or IgE. We therefore think it is unlikely that prenatal alcohol exposure in pregnancy protects against asthma and other atopic disease.   
In ALSPAC, mothers carrying the minor A allele consumed less alcohol during pregnancy.  Previous in vitro data suggested that carriers of this allele metabolise alcohol up to 100 times faster than individuals homozygous for the G allele36, and consequently consume less alcohol to avoid the negative effects of high acetaldehyde concentrations; this in turn would reduce exposure of the fetus to alcohol, which readily crosses the placenta. Whilst a more recent study has suggested that this variant makes a minor contribution to the variation in alcohol metabolism in vivo37, lack of power because of the variant’s low frequency in European populations is the most likely explanation for this.  As a matter of fact, the utility of ADH1B genotype as a Mendelian randomization instrument has been clearly demonstrated in relation to alcohol-induced cancer27;33.  

Strengths and limitations
Our study has a number of strengths, including ALSPAC’s population-based prospective design and rich data on maternal reported alcohol use in pregnancy, potential confounders and detailed phenotypic outcome measurements.  Also, few other birth cohorts have maternal DNA available.  Measurement of maternal ADH1B genotype enabled us to use a Mendelian randomization approach to investigate the relation between prenatal alcohol exposure and atopic outcomes.  In contrast, the  majority of previous epidemiological studies of the effects of maternal alcohol use in pregnancy on offspring health have relied on reported consumption, an approach which is highly susceptible to bias and confounding.  Whilst there was potential for associations with ADH1B genotype to be confounded by population substructure, we reduced this possibility by excluding those with reported non-white ethnicity and by carrying out sensitivity analyses in which we controlled for PCA variables derived from GWAS data. We acknowledge, however, that given the low minor allele frequency for rs1229984, we lacked power to detect small or modest effects of this variant, as indicated by the confidence intervals around the effect estimates, and also power to detect interactions with reported alcohol intake. We also accept that we have not taken into account the ability of the fetus to metabolise alcohol, and hence the potential effect of gene variants in the child on atopic outcomes.  Nevertheless, we would argue that the maternal ADH1B gene is likely to have a greater influence on fetal alcohol exposure because it is so strongly associated with maternal drinking behaviour.  As with any longitudinal study, data were not complete on exposures, outcomes and confounders for the whole cohort.  Therefore we cannot rule out the possibility that exclusion of children without complete information might have biased our findings with respect to reported alcohol intake; however, importantly, it is unlikely that missing genotype data would bias the main genetic results. 

Public health implications
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